Ganesh Benzoplast to discuss Q4FY26 results on June 8

Ganesh Benzoplast Limited will host an investor and analyst conference call on June 8, 2026, to review its financial performance for the quarter ended March 31, 2026. The management will discuss the audited results and provide an outlook for the business during the session scheduled for 2:30 PM IST.

The announcement was made pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The conference call allows stakeholders to gain direct insights into the company's operational achievements and future strategies.

Conference Call Details

The event will feature key members of the company's leadership, including Mr. Rishi Pilani, Chairman & Managing Director, and Mr. Amar Kabra, GM-Finance & Taxation. Participants can join the discussion using the universal dial-in numbers provided for domestic and international access.

Dial-in Numbers

Type	Number
Primary	+91 22 6280 1442
Alternate	+91 22 7115 8327

International participants can access the call via toll-free numbers designated for various countries, including the USA, UK, Singapore, and Australia. The full list of international access numbers is available on the company's website.

Investors wishing to attend the conference call are requested to confirm their participation by contacting the company officials. Ms. Ekta Dhanda, Company Secretary & Compliance Officer, and Mr. Manoj Khandekar, IT-Manager, are the designated points of contact for RSVPs.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-3.10%	-4.42%	-6.18%	+13.71%	-16.02%	+1.88%

Ganesh Benzoplast reported its audited consolidated financial results for the year ended March 31, 2026, recording a net profit of ₹733.36 million, a significant increase from ₹380.86 million in the previous year. The company’s revenue from operations for FY26 stood at ₹4,114.19 million, compared to ₹3,743.11 million in FY25, driven by growth across its LST and Chemical divisions. For the quarter ended March 31, 2026, the company posted a consolidated net profit of ₹152.94 million, reversing the net loss of ₹131.92 million reported in the corresponding quarter of the previous year.

Financial Performance

The board approved the standalone and consolidated audited financial results on May 27, 2026. Revenue for Q4FY26 increased to ₹1,114.70 million from ₹999.34 million in Q4FY25. The statutory auditors, M/s. Mittal & Associates, issued an unmodified opinion on the standalone and consolidated financial results.

The following table summarizes the key consolidated financial metrics for FY26:

Metric:	FY26 (Audited)	FY25 (Audited)
Revenue from Operations:	₹4,114.19 million	₹3,743.11 million
Total Income:	₹4,368.57 million	₹3,920.04 million
Profit Before Tax:	₹980.15 million	₹519.22 million
Net Profit:	₹733.36 million	₹380.86 million
Earnings Per Share (Basic):	₹10.19	₹5.29

Segment Performance

The LST Division reported segment revenue of ₹2,258.73 million for FY26, up from ₹2,004.81 million in the prior year. The Chemical Division recorded revenue of ₹1,855.45 million, compared to ₹1,738.30 million in FY25. Total segment assets for the group stood at ₹7,183.20 million as of March 31, 2026.

Corporate Governance and Auditors

The board appointed M/s S.K Agarwal & Associates, Cost Accountants, as the Cost Auditors for FY 2026-27. Additionally, M/s. V K Baheti & Co., Chartered Accountants, were appointed as Internal Auditors for the financial year 2026-27.

Strategic Initiatives

The board initiated the process to form a wholly-owned subsidiary company in Singapore to explore future business opportunities and promote business development in the region. The formation is subject to compliance with applicable statutory and regulatory requirements in India and Singapore.